Literature DB >> 10404403

Flow cytometric analysis of in vitro proinflammatory cytokine secretion in peripheral blood from multiple sclerosis patients.

L T Nguyen1, M Ramanathan, F Munschauer, C Brownscheidle, S Krantz, M Umhauer, C Miller, E DeNardin, L D Jacobs.   

Abstract

The cytokines, interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha), and interleukin-2 (IL-2) are important endogenous proinflammatory proteins and have been linked to disease activity in multiple sclerosis. In this study, we use flow cytometric methodology to compare the secretion of IFN-gamma, IL-2, and TNF-alpha from peripheral blood-derived T cells of multiple sclerosis patients to the secretion in healthy controls. The percentages of IFN-gamma, IL-2, and TNF-alpha secreting cells are not significantly different between multiple sclerosis patients and controls. However, the TNF-alpha secreting CD3 cell percentage is correlated with the IFN-gamma and IL-2 secreting CD3 cell percentages in multiple sclerosis patients. In the controls, only the TNF-alpha secreting CD3 cell percentage is correlated with IFN-gamma. These findings show that correlated secretion of cytokines occurs in multiple sclerosis and suggest that concerted intercytokine interactions may play an important role in the disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10404403     DOI: 10.1023/a:1020555711228

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  28 in total

1.  Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).

Authors:  R A Rudick; D E Goodkin; L D Jacobs; D L Cookfair; R M Herndon; J R Richert; A M Salazar; J S Fischer; C V Granger; J H Simon; J J Alam; N A Simonian; M K Campion; D M Bartoszak; D N Bourdette; J Braiman; C M Brownscheidle; M E Coats; S L Cohan; D S Dougherty; R P Kinkel; M K Mass; F E Munschauer; R L Priore; R H Whitham
Journal:  Neurology       Date:  1997-08       Impact factor: 9.910

2.  In vitro TNF-alpha, IL-2 and IFN-gamma production as markers of relapses in multiple sclerosis.

Authors:  J Philippé; J Debruyne; G Leroux-Roels; A Willems; J Dereuck
Journal:  Clin Neurol Neurosurg       Date:  1996-11       Impact factor: 1.876

3.  Therapeutic and toxic activity of tumor necrosis factor is synergistic with gamma interferon.

Authors:  J E Talmadge; O Bowersox; H Tribble; M Shepard; D Liggitt
Journal:  Pathol Immunopathol Res       Date:  1989

4.  Detection of altered T helper 1 and T helper 2 cytokine production by peripheral blood mononuclear cells in patients with multiple sclerosis utilizing intracellular cytokine detection by flow cytometry and surface marker analysis.

Authors:  B Crucian; P Dunne; H Friedman; R Ragsdale; S Pross; R Widen
Journal:  Clin Diagn Lab Immunol       Date:  1996-07

5.  Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis.

Authors:  A Noronha; A Toscas; M A Jensen
Journal:  J Neuroimmunol       Date:  1993-07       Impact factor: 3.478

6.  Interferon-gamma and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions.

Authors:  U Traugott; P Lebon
Journal:  J Neurol Sci       Date:  1988-04       Impact factor: 3.181

7.  Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

Authors:  L D Jacobs; D L Cookfair; R A Rudick; R M Herndon; J R Richert; A M Salazar; J S Fischer; D E Goodkin; C V Granger; J H Simon; J J Alam; D M Bartoszak; D N Bourdette; J Braiman; C M Brownscheidle; M E Coats; S L Cohan; D S Dougherty; R P Kinkel; M K Mass; F E Munschauer; R L Priore; P M Pullicino; B J Scherokman; R H Whitham
Journal:  Ann Neurol       Date:  1996-03       Impact factor: 10.422

8.  Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis.

Authors:  J Correale; W Gilmore; M McMillan; S Li; K McCarthy; T Le; L P Weiner
Journal:  J Immunol       Date:  1995-03-15       Impact factor: 5.422

9.  Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors.

Authors:  M A Collart; D Belin; J D Vassalli; S de Kossodo; P Vassalli
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

10.  Heterogeneity of single cell cytokine gene expression in clonal T cell populations.

Authors:  R P Bucy; A Panoskaltsis-Mortari; G Q Huang; J Li; L Karr; M Ross; J H Russell; K M Murphy; C T Weaver
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more
  3 in total

1.  Sex hormone levels correlate with the activity of cytokine-secreting cells in vivo.

Authors:  D Verthelyi; D M Klinman
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

2.  Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis.

Authors:  Marina Zafranskaya; Patrick Oschmann; Rosel Engel; Andreas Weishaupt; Johannes M van Noort; Hassan Jomaa; Matthias Eberl
Journal:  Immunology       Date:  2006-12-18       Impact factor: 7.397

3.  Circulating lymphocyte subsets linked to intracellular cytokine profiles in normal humans.

Authors:  M Matsui; S Araya; H-Y Wang; N Onai; K Matsushima; T Saida
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.